209 related articles for article (PubMed ID: 28499961)
1. Towards an improved global understanding of treatment and outcomes in people with type 2 diabetes: Rationale and methods of the DISCOVER observational study program.
Ji L; Bonnet F; Charbonnel B; Gomes MB; Kosiborod M; Khunti K; Nicolucci A; Pocock S; Rathmann W; Shestakova MV; Shimomura I; Watada H; Fenici P; Hammar N; Hashigami K; Macaraeg G; Surmont F; Medina J
J Diabetes Complications; 2017 Jul; 31(7):1188-1196. PubMed ID: 28499961
[TBL] [Abstract][Full Text] [Related]
2. The 2018 update of the American College of Physicians glycaemic management recommendations: An invitation to continued inertia?
Morales J; Assumpcao-Morales M
Diabetes Obes Metab; 2018 Aug; 20(8):1809-1811. PubMed ID: 29658190
[TBL] [Abstract][Full Text] [Related]
3. HbA1c response after insulin initiation in patients with type 2 diabetes mellitus in real life practice: Identifying distinct subgroups.
Sidorenkov G; van Boven JFM; Hoekstra T; Nijpels G; Hoogenberg K; Denig P
Diabetes Obes Metab; 2018 Aug; 20(8):1957-1964. PubMed ID: 29687577
[TBL] [Abstract][Full Text] [Related]
4. Improving type 2 diabetes mellitus glycaemic outcomes is possible without spending more on medication: Lessons from the UK National Diabetes Audit.
Heald AH; Livingston M; Malipatil N; Becher M; Craig J; Stedman M; Fryer AA
Diabetes Obes Metab; 2018 Jan; 20(1):185-194. PubMed ID: 28730750
[TBL] [Abstract][Full Text] [Related]
5. Therapeutic inertia in the treatment of hyperglycaemia in patients with type 2 diabetes: A systematic review.
Khunti K; Gomes MB; Pocock S; Shestakova MV; Pintat S; Fenici P; Hammar N; Medina J
Diabetes Obes Metab; 2018 Feb; 20(2):427-437. PubMed ID: 28834075
[TBL] [Abstract][Full Text] [Related]
6. Analysis of English general practice level data linking medication levels, service activity and demography to levels of glycaemic control being achieved in type 2 diabetes to improve clinical practice and patient outcomes.
Heald A; Davies M; Stedman M; Livingston M; Lunt M; Fryer A; Gadsby R
BMJ Open; 2019 Sep; 9(9):e028278. PubMed ID: 31494602
[TBL] [Abstract][Full Text] [Related]
7. A Multicenter Real-Life Study on the Effect of Flash Glucose Monitoring on Glycemic Control in Patients with Type 1 and Type 2 Diabetes.
Anjana RM; Kesavadev J; Neeta D; Tiwaskar M; Pradeepa R; Jebarani S; Thangamani S; Sastry NG; Brijendra Kumar S; Ramu M; Gupta PPK; Vignesh J; Chandru S; Kayalvizhi S; Jagdish PS; Uthra SCB; Lovelena M; Jyoti S; Suguna Priya S; Kannan A; Mohan V; Unnikrishnan R
Diabetes Technol Ther; 2017 Sep; 19(9):533-540. PubMed ID: 28930495
[TBL] [Abstract][Full Text] [Related]
8. Managing glycaemia in older people with type 2 diabetes: A retrospective, primary care-based cohort study, with economic assessment of patient outcomes.
Gordon J; McEwan P; Evans M; Puelles J; Sinclair A
Diabetes Obes Metab; 2017 May; 19(5):644-653. PubMed ID: 28026911
[TBL] [Abstract][Full Text] [Related]
9. Intensive glycemic control in younger and older U.S. adults with type 2 diabetes.
Casagrande S; Cowie CC; Fradkin JE
J Diabetes Complications; 2017 Aug; 31(8):1299-1304. PubMed ID: 28571934
[TBL] [Abstract][Full Text] [Related]
10. Treatment patterns among older patients with type 2 diabetes in the United States: a retrospective cohort study.
Fu H; Curtis BH; Schuster DP; Festa A; Kendall DM
Diabetes Technol Ther; 2014 Dec; 16(12):833-9. PubMed ID: 25068375
[TBL] [Abstract][Full Text] [Related]
11. Impact of Current and Emerging Glucose-Lowering Drugs on Body Weight in Type 2 Diabetes.
Lau DC; Teoh H
Can J Diabetes; 2015 Dec; 39 Suppl 5():S148-54. PubMed ID: 26654858
[TBL] [Abstract][Full Text] [Related]
12. Therapeutic inertia in patients treated with two or more antidiabetics in primary care: Factors predicting intensification of treatment.
Mata-Cases M; Franch-Nadal J; Real J; Gratacòs M; López-Simarro F; Khunti K; Mauricio D
Diabetes Obes Metab; 2018 Jan; 20(1):103-112. PubMed ID: 28656746
[TBL] [Abstract][Full Text] [Related]
13. Insights into optimal basal insulin titration in type 2 diabetes: Results of a quantitative survey.
Berard L; Bonnemaire M; Mical M; Edelman S
Diabetes Obes Metab; 2018 Feb; 20(2):301-308. PubMed ID: 28719066
[TBL] [Abstract][Full Text] [Related]
14. An alternative approach to modelling HbA1c trajectories in patients with type 2 diabetes mellitus.
McEwan P; Bennett H; Qin L; Bergenheim K; Gordon J; Evans M
Diabetes Obes Metab; 2017 May; 19(5):628-634. PubMed ID: 28026908
[TBL] [Abstract][Full Text] [Related]
15. Relationship of glycated haemoglobin and reported hypoglycaemia to cardiovascular outcomes in patients with type 2 diabetes and recent acute coronary syndrome events: The EXAMINE trial.
Heller SR; Bergenstal RM; White WB; Kupfer S; Bakris GL; Cushman WC; Mehta CR; Nissen SE; Wilson CA; Zannad F; Liu Y; Gourlie NM; Cannon CP;
Diabetes Obes Metab; 2017 May; 19(5):664-671. PubMed ID: 28058763
[TBL] [Abstract][Full Text] [Related]
16. Benefits of timely basal insulin control in patients with type 2 diabetes.
Lovre D; Fonseca V
J Diabetes Complications; 2015 Mar; 29(2):295-301. PubMed ID: 25536866
[TBL] [Abstract][Full Text] [Related]
17. Patient-Centered Guidelines for Geriatric Diabetes Care: Potential Missed Opportunities to Avoid Harm.
McCreedy EM; Kane RL; Gollust SE; Shippee ND; Clark KD
J Am Board Fam Med; 2018; 31(2):192-200. PubMed ID: 29535235
[TBL] [Abstract][Full Text] [Related]
18. Delays in treatment intensification with oral antidiabetic drugs and risk of microvascular and macrovascular events in patients with poor glycaemic control: An individual patient simulation study.
Folse HJ; Mukherjee J; Sheehan JJ; Ward AJ; Pelkey RL; Dinh TA; Qin L; Kim J
Diabetes Obes Metab; 2017 Jul; 19(7):1006-1013. PubMed ID: 28211604
[TBL] [Abstract][Full Text] [Related]
19. Clinical inertia with regard to intensifying therapy in people with type 2 diabetes treated with basal insulin.
Khunti K; Nikolajsen A; Thorsted BL; Andersen M; Davies MJ; Paul SK
Diabetes Obes Metab; 2016 Apr; 18(4):401-9. PubMed ID: 26743666
[TBL] [Abstract][Full Text] [Related]
20. Subgroup analysis of phase 3 studies of dulaglutide in Japanese patients with type 2 diabetes.
Onishi Y; Oura T; Nishiyama H; Ohyama S; Takeuchi M; Iwamoto N
Endocr J; 2016; 63(3):263-73. PubMed ID: 26698689
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
